Does NIVOLUMAB Cause Cholangitis? 389 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 389 reports of Cholangitis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.4% of all adverse event reports for NIVOLUMAB.
389
Reports of Cholangitis with NIVOLUMAB
0.4%
of all NIVOLUMAB reports
50
Deaths
223
Hospitalizations
How Dangerous Is Cholangitis From NIVOLUMAB?
Of the 389 reports, 50 (12.9%) resulted in death, 223 (57.3%) required hospitalization, and 14 (3.6%) were considered life-threatening.
Is Cholangitis Listed in the Official Label?
Yes, Cholangitis is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Cholangitis?
PEMBROLIZUMAB (357)
PACLITAXEL (289)
GEMCITABINE (225)
TACROLIMUS (213)
BEVACIZUMAB (176)
FLUOROURACIL (175)
DURVALUMAB (157)
OXALIPLATIN (147)
IRINOTECAN (146)
ATEZOLIZUMAB (145)
Which NIVOLUMAB Alternatives Have Lower Cholangitis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE